ArticleCardio-oncology (London, England)2026
Left-sided mastectomy mimics LVEF decline on CZT-ERNA: a consideration for cardio-oncology practice.
Article in Cardio-oncology (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMonitoring of left ventricular ejection fraction (LVEF) is essential in patients receiving potentially cardiotoxic cancer therapies. Equilibrium radionuclide angiography (ERNA) remains an established method for quantitative assessment of LVEF. However, the absence of attenuation correction may render the method sensitive to anatomical changes, such as those caused by mastectomy. The aim with this study was to investigate whether left-sided mastectomy systematically affects the estimation of LVEF using cadmium-zinc-telluride (CZT)-based ERNA.
methodsThis retrospective single-centre cohort study included breast cancer patients who had undergone unilateral or bilateral mastectomy and had both pre- and postoperative CZT-ERNA performed under identical acquisition protocols. Pre- to postoperative changes in LVEF, left ventricular end-diastolic volume (LVEDV), and left ventricular end-systolic volume (LVESV) were compared between left- and right-sided mastectomy groups.
resultsBetween-group comparison showed that left-sided mastectomy (including bilateral) was associated with a significant decrease in LVEF (mean change -4.0 percentage points, 95% CI -6.0 to -2.0, p = 0.011). In contrast, no significant within-group change was observed for right-sided mastectomy (mean change 0.6 percentage points, 95% CI -2.4 to 3.6, p = 0.7). One in four patients (25%) in the left-sided group experienced a decline in LVEF of at least 10 percentage points, compared with 1 in 17 in the right-sided group. Multivariable regression analysis indicated that LVEF decline was independently associated with mastectomy laterality, whereas cumulative anthracycline dose and radiotherapy were non-significant.
conclusionLeft-sided mastectomy is associated with a significant decrease in LVEF measured by CZT-ERNA. This finding likely reflects improved delineation of LVESV rather than true systolic decline. Recent chest surgery and individual anatomical changes should be considered when interpreting serial CZT-ERNA examinations. Confirmatory imaging may be warranted in cases of unexpected or pronounced LVEF declines.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.